Literature DB >> 19255722

feG-COOH blunts eosinophilic airway inflammation in a feline model of allergic asthma.

Amy E DeClue1, Elizabeth Schooley, Laura A Nafe, Carol R Reinero.   

Abstract

OBJECTIVE AND
DESIGN: This study investigated if feG-COOH would decrease allergen-induced airway inflammation. MATERIALS OR
SUBJECTS: Seven adult cats sensitised to Bermuda grass allergen (BGA) to induce an asthmatic phenotype. TREATMENT: Cats were randomized to receive either feG-COOH (1 mg/kg, PO) or placebo (saline 1 ml, PO) immediately prior to BGA aerosol challenge in a cross-over design.
METHODS: Bronchoalveolar lavage fluid (BALF) was collected and airway inflammatory response assessed via inflammatory cell number and type; IL-4, IFN-gamma and nitric oxide metabolite concentrations. A paired t test was used to compare parameters with a P < 0.05 considered significant.
RESULTS: The BALF eosinophil percentage was significantly lower in asthmatic cats treated with feG compared with placebo (placebo, 35.3 +/- 12.2%; feG, 22.4 +/- 8.6%; P = 0.002). Treatment with feG did not result in a significant change in any other parameter measured.
CONCLUSIONS: These data indicate that a single dose of feG-COOH partially attenuates eosinophilic airway inflammation in experimental feline asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255722     DOI: 10.1007/s00011-009-0010-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  25 in total

Review 1.  Bronchoalveolar lavage in the evaluation of pulmonary disease in the dog and cat. State of the art.

Authors:  E C Hawkins; D B DeNicola; N F Kuehn
Journal:  J Vet Intern Med       Date:  1990 Sep-Oct       Impact factor: 3.333

2.  Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1).

Authors:  R E Dery; R Mathison; J Davison; A D Befus
Journal:  Int Arch Allergy Immunol       Date:  2001 Jan-Mar       Impact factor: 2.749

Review 3.  Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases.

Authors:  H Yssel; H Groux
Journal:  Int Arch Allergy Immunol       Date:  2000-01       Impact factor: 2.749

Review 4.  Autonomic innervation of human airways: structure, function, and pathophysiology in asthma.

Authors:  V H van der Velden; A R Hulsmann
Journal:  Neuroimmunomodulation       Date:  1999 May-Jun       Impact factor: 2.492

5.  Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats.

Authors:  B M Corcoran; D J Foster; V L Fuentes
Journal:  J Small Anim Pract       Date:  1995-11       Impact factor: 1.522

6.  Bronchodilatation: noncholinergic, nonadrenergic mediation demonstrated in vivo in the cat.

Authors:  C G Irvin; R Boileau; J Tremblay; R R Martin; P T Macklem
Journal:  Science       Date:  1980-02-15       Impact factor: 47.728

7.  Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma.

Authors:  Carol R Reinero; Leah A Cohn; Cherlene Delgado; Christine M Spinka; Elizabeth K Schooley; Amy E DeClue
Journal:  Vet Immunol Immunopathol       Date:  2007-10-02       Impact factor: 2.046

8.  In vivo bronchodilator activity of vasoactive intestinal peptide in the cat.

Authors:  L Diamond; J L Szarek; M N Gillespie; R J Altiere
Journal:  Am Rev Respir Dis       Date:  1983-11

9.  Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats.

Authors:  P Padrid; S Snook; T Finucane; P Shiue; P Cozzi; J Solway; A R Leff
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

Review 10.  Asthma: mechanisms of disease persistence and progression.

Authors:  Lauren Cohn; Jack A Elias; Geoffrey L Chupp
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  3 in total

1.  Calcium-binding protein, spermatid-specific 1 is expressed in human salivary glands and contains an anti-inflammatory motif.

Authors:  Chris D St Laurent; Katherine E St Laurent; Ron D Mathison; A Dean Befus
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-01-28       Impact factor: 3.619

2.  Salivary gland derived peptides as a new class of anti-inflammatory agents: review of preclinical pharmacology of C-terminal peptides of SMR1 protein.

Authors:  Ronald D Mathison; Joseph S Davison; A Dean Befus; Daniel A Gingerich
Journal:  J Inflamm (Lond)       Date:  2010-09-28       Impact factor: 4.981

Review 3.  Animal models of asthma: utility and limitations.

Authors:  Marcelo Vivolo Aun; Rafael Bonamichi-Santos; Fernanda Magalhães Arantes-Costa; Jorge Kalil; Pedro Giavina-Bianchi
Journal:  J Asthma Allergy       Date:  2017-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.